Peripheral effects Via the AMY2 and AMY3 receptors Cagrilintide acts peripherally: Slowing of gastric emptying , stronger than with GLP-1 Suppression of postprandial glucagon , helps control postprandial glycemic spikes Modulation of bone remodeling (via AMY3), a neutral effect, but clinically monitored Synergy with GLP-1 (the mechanistic basis of CagriSema) The main innovation is the complementarity with the GLP-1 pathway : GLP-1 suppresses appetite via the arcuate nucleus of the hypothalamus (POMC neurons, AgRP/NPY inhibition) Amylin suppresses appetite via the area postrema (CGRP-like neurons) Two independent centers, two independent mechanisms
Studies have shown that the peptide can increase the lifespan and longevity of mammalian cells (Khavinson et al 2003a, b, Khavinson et al 2000, Khavinson et al 2017, Anisimov and Khavinson 2010), through the activation of telomerase, which results in telomere length extension (Khavinson et al 2003a, b)
How is DSIP supplied
Don't hesitate to reach out and learn more about how we can assist you
User Reviews and Experiences I must say that user reviews on AOD 9604 are quite mixed
Higher concentrations (3%+) are best reserved for experienced users or targeted use, as they raise the risk of irritation and staining without clearly proportional benefits